Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
245 hedge funds and large institutions have $2.81B invested in Inari Medical, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 77 reducing their positions, and 30 closing their positions.
37% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 30
19% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 77
3% more funds holding
Funds holding: 239 → 245 (+6)
12% less call options, than puts
Call options by funds: $3.29M | Put options by funds: $3.73M
17% less capital invested
Capital invested by funds: $3.4B → $2.81B (-$594M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$73.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$53.6M |
| 3 |
BlackRock
New York
|
+$18.5M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.2M |
| 5 |
JP Morgan Chase
New York
|
+$14.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$207M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$51.7M |
| 3 |
Millennium Management
New York
|
-$31.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$23.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.9M |
NARI Hedge Fund Activity: Q4 2022 in Review
245 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q4 2022, worth a combined $2.81B — down 17% from $3.4B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NARI positions and 30 closed out — a net gain of 11 holders — while 92 added to existing stakes and 77 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $73.9M. The largest seller was Capital International Investors, cutting an estimated $207M.
- 245 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q4 2022, up from 239 in Q3 2022.
- Funds reported $2.81B of Inari Medical, Inc. Common Stock stock for Q4 2022, down 17% quarter-over-quarter.
- 41 funds opened new Inari Medical, Inc. Common Stock positions in Q4 2022 and 30 closed out, a net change of +11 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q4 2022 was Morgan Stanley, an estimated $73.9M added.
- The largest Inari Medical, Inc. Common Stock seller in Q4 2022 was Capital International Investors, an estimated $207M sold.
Based on aggregated 13F filings for Q4 2022.